<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02298738</url>
  </required_header>
  <id_info>
    <org_study_id>AnkaraU</org_study_id>
    <nct_id>NCT02298738</nct_id>
  </id_info>
  <brief_title>Effect of Vit D on New-onset AF in Hypertension</brief_title>
  <official_title>Relation of Low Vitamin D Levels and New-onset AF Among Hypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF), an important cause of cardiac mortality and morbidity is the most&#xD;
      common type of cardiac arrhythmia in clinical practice. Hypertensive individuals are at&#xD;
      particular risk of development of atrial fibrillation. Renin-angiotensin-aldosteron system&#xD;
      (RAS) which is activated in hypertension may be the underlying mechanism of AF among&#xD;
      hypertensive patients.&#xD;
&#xD;
      Vitamin D deficiency has been shown to be involved in the pathogenesis of hypertension,&#xD;
      cardiovascular disease and obesity. Increased RAS activity is one of the postulated&#xD;
      mechanisms by which vitamin D deficiency may trigger the development of hypertension and&#xD;
      various cardiovascular diseases. On the basis of these data we hypothesized that&#xD;
      hypovitaminosis D might be associated with new-onset AF among patients with hypertension.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>hypovitaminosis D</measure>
    <time_frame>Baseline</time_frame>
    <description>Identifying whether hypovitaminosis D is a risk factor for development of new-onset AF among hypertensive patients</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">227</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>New onset Atrial fibrillation</arm_group_label>
    <description>New-onset AF was defined as patients with hypertension and atrial fibrillation which was identified for the first time by an electrocardiogram or ambulatory holter monitoring.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>Hypertensive patients without atrial fibrillation.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Hypertensive patients with new-onset AF. New onset AF was defined as AF identified for the&#xD;
        first time by an electrocardiogram or ambulatory holter monitoring. Hypertension was&#xD;
        defined as blood pressure ≥ 140/90 mmHg or a history of antihypertensive drug use.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hypertensive patients with new-onset AF&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Established coronary artery disease&#xD;
&#xD;
          -  Heart failure&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Significant heart valve disease&#xD;
&#xD;
          -  Hyperthyroidism&#xD;
&#xD;
          -  Renal failure&#xD;
&#xD;
          -  Any malignancy&#xD;
&#xD;
          -  Acute infection&#xD;
&#xD;
          -  Recent thoracic or abdominal surgery&#xD;
&#xD;
          -  Under therapy of Vit D3&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2014</verification_date>
  <study_first_submitted>November 20, 2014</study_first_submitted>
  <study_first_submitted_qc>November 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>November 21, 2014</last_update_submitted>
  <last_update_submitted_qc>November 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>Özgür Ulaş Özcan</investigator_full_name>
    <investigator_title>Dr Ozgur Ulas Ozcan</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation, hypertension, vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

